Ablation of TIMP-3 in mouse enhanced inflammation by dysregulating the activity of ADAM17 (a TIMP-3 target metalloproteinase) and the subsequent release of its substrate TNF, thus promoting insulin resistance and hepatosteatosis [5]. The gene discussed is TIMP3; the disease is Insulin resistance.